ANGPTL3 deficiency alters the lipid profile and metabolism of cultured hepatocytes and human lipoproteins-Reference-Cited by-同舟云学术

ANGPTL3 deficiency alters the lipid profile and metabolism of cultured hepatocytes and human lipoproteins

Published:2020-07 Issue:7 Volume:1865 Page:158679
ISSN:1388-1981
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids

Author:

Ruhanen Hanna,Haridas P.A. Nidhina,Minicocci Ilenia,Taskinen Juuso H.,Palmas Francesco,di Costanzo Alessia,D'Erasmo Laura,Metso Jari,Partanen Jennimari,Dalli Jesmond,Zhou You,Arca Marcello,Jauhiainen Matti,Käkelä Reijo,Olkkonen Vesa M.

Funder

Novo Nordisk Foundation

Paavo Nurmi Foundation

Liv och Hälsa Foundation

Finnish Foundation for Cardiovascular Research

Jane and Aatos Erkko Foundation

Magnus Ehrnrooth Foundation

Sapienza University of Rome

European Research Council

Barts Charity

Wellcome Trust

Royal Society

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference80 articles.

1. WHO, 2018. World Health Organization fact sheet: the top 10 causes of death 2019. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. 24 May 2018 (accessed 2 January 2020).

2. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines;Stone;Circulation,2014

3. Lipid-lowering agents;Hegele;Circ. Res.,2019

4. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism;Köster;Endocrinology,2005

5. ANGPTL8 blockade with a monoclonal antibody promotes triglyceride clearance, energy expenditure, and weight loss in mice;Gusarova;Endocrinology,2017

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipoprotein Lipidomics as a Frontier in Non-Alcoholic Fatty Liver Disease Biomarker Discovery;International Journal of Molecular Sciences;2024-07-29

2. Gene Silencing of Angiopoietin-like 3 (ANGPTL3) Induced De Novo Lipogenesis and Lipid Accumulation in Huh7 Cell Line;International Journal of Molecular Sciences;2024-03-26

3. Liver cancer cells as the model for developing liver-targeted RNAi therapeutics;Biochemical and Biophysical Research Communications;2023-02

4. New and Emerging Therapies for Dyslipidemia;Endocrinology and Metabolism Clinics of North America;2022-09

5. Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia;Clinical Pharmacology: Advances and Applications;2022-07